Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hotel Casa Amsterdam

Nov 06, 2024 8:00 AM - Nov 07, 2024 6:00 PM

Eerste Ringdijkstraat 4, NL-1097 Amsterdam, Netherlands

Global Forum for Qualified Persons for Pharmacovigilance (QPPV)

Early Bird ending in

DAYS

HOURS

MINUTES

SECONDS

Overview

 

Celebrating its 18th year, the DIA Global QPPV Forum continues to be the only forum designed for QPPVs by QPPVs. This unique platform provides a safe and trustworthy environment for QPPVs to exchange information, get inspired by colleagues, and network with peers that they only meet at this conference. The forum is not just a valuable opportunity to network, but also an educational conference that offers a broad perspective on the field. With a focus on practical cases and solutions, it’s a great place to present challenges and collectively find solutions with your peers.

 

Participant Testimonials

"Love the general feel of the meeting - friendly, open, honest and all willing to share and learn."

"I heard a lot of valuable input for topics under discussion in my company."

"A great gathering of experts discussing relevant topics."

Featured topics

  • Global QPPV challenges
  • Trends requiring QPPV awareness
  • Impact of modern technology on the field
  • AI and Digitalisation
  • Harmonisation
  • Impact of new local requirements for international Qualified Persons (QPs).
  • Local QPPVs network
  • Data privacy
  • Globalising the PSMF – Tool for Global Understanding
  • Interaction Between the Different Local QPPVs (EU and non-EU) and the EU QPPV
  • QPPV Oversight
  • Inspections

Featured

Want to learn more about Global Forum for Qualified Persons for Pharmacovigilance (QPPV)? You've come to the right site!

Exhibits

Who should attend?

  • QPPVs and Deputies from any territory
  • Regulators
  • Pharmacovigilance Consultants
  • Directors of Pharmacovigilance Oversight and Standards
  • Drug Safety Managers/ Leaders
  • Auditors
  • Medical and Regulatory Affairs Experts
  • Aspiring PV Specialists/QPPVs
  • QPPV Support Staff

Learning objectives

The DIA Global QPPV Forum is the premier platform designed exclusively for QPPVs to engage in meaningful exchanges. Bringing together professionals from diverse backgrounds, including small to large pharmaceutical companies and consultants, this forum offers unparalleled networking opportunities.

Attendees benefit from direct access to regulators and inspectors, facilitating valuable interactions and discussions. The agenda includes new topics such as the evolving role of QPPVs in different organisational settings (big pharma, small pharma, CROs), as well as insights into QPPV requirements and expectations in non-EU countries.

  • Upon completion, learners should be able to:

    • Hear the latest updates and hot topics relating to the role of QPPV
    • Explore long-term PV visions, future directions of the the future directions of the ‘PV world’ and potential impact on the role of the QPPV
    • Network with colleagues and meet regulators
    • Learn from and share experiences and ideas with like-minded QPPVs in a neutral environment
    • Better uderstand regulatory and inspectorate expectations globally
    • Examine current challenges and share potential solutions

Short Course or Primer

To keep you at the forefront.

Nov 05, 2024

Pre-conference Tutorials:

Introduction to the Role of QPPVs

Nov 05, 2024

Pre-Conference Tutorials:

Globalisation of PSMF

Program Committee

  • Gemma  Jimenez Sese
    Gemma Jimenez Sese Senior Director, Deputy EU QPPV
    AstraZeneca, Spain
  • Maarten  Lagendijk, MSc
    Maarten Lagendijk, MSc Deputy EU QPPV
    MSD, Netherlands
  • Angela  Van Der Salm, PhD, MSc
    Angela Van Der Salm, PhD, MSc Director PV, Managing partner
    DADA Consultancy B.V., Netherlands
  • Shahinaz  Badr
    Shahinaz Badr Pharmacovigilance Consultant and PVQA Auditor - EMEA
    Pharma Quality Europe, United Arab Emirates
  • Vicki  Edwards, RPh
    Vicki Edwards, RPh Vice President, Pharmacovigilance Excellence and International QPPV
    Abbvie, United Kingdom
  • Magnus  Ysander, MD
    Magnus Ysander, MD EU & UK QPPV & Head Pharmacovigilance Excellence
    AstraZeneca, Sweden
  • Elspeth  McIntosh, MBA, RN
    Elspeth McIntosh, MBA, RN Director
    Castle Pharmacovigilance Ltd, United Kingdom
  • Katarzyna  Swiderek, MPharm, RPh
    Katarzyna Swiderek, MPharm, RPh Director, Safety Evaluation Risk Management (SERM)
    GlaxoSmithKline, Poland
  • Claire  Longman, MSc
    Claire Longman, MSc Expert Pharmacovigilance Inspector
    Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
  • Willemijn  van der Spuij, MSc
    Willemijn van der Spuij, MSc Executive Director, WorldWide Patient Safety International, Europe
    Switzerland

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.